Surgalign Holdings (SRGA) reported Q2 EPS of ($0.86), $1.39 better than the analyst estimate of ($2.25). Revenue for the quarter came in at $20.6 million versus the consensus estimate of $21.13 million.
Surgalign Holdings (SRGA) reported Q2 EPS of ($0.86), $1.39 better than the analyst estimate of ($2.25). Revenue for the quarter came in at $20.6 million versus the consensus estimate of $21.13 million.